Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · LASA

LASA

HealthcarePharmaceuticals & Biotechnology₹22 cr market cap
— As of 19 Nov 2026
52-week low ₹4.0152-week high ₹12.04

-66.7% from the 52-week high · +0.0% above the low

Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-09-21. The firm is engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, pharmaceuticals, drugs and others. The company specializes in catalyst chemistry and manufactures anthelmintic/veterinary API products. The firm's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Albendazole, Fenbendazole, Oxfendazole, Providone Iodine, Nitroxylene, Ricobendazole, Halquinol and others. Its animal feed ingredients include potassium iodide, cobalt sulfate, sodium selenate, ethylediamine dihydroiodide and vanadyl sulfate. Its reagents for therapeutic use include cetylpyridinium chloride, bismuth subsalicylate and sodium selenite. The firm's manufacturing facility is located at Mahad and Chiplun, Maharashtra.

The short version. Promoter holding was 53.65% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

LASA trades 66.7% below its 52-week high and 0.0% above its 52-week low.

Change over period: —

1M-22.3%
3M-43.8%
6M-47.9%
1Y-60.9%

4 · The owners

Who holds it, and are they adding?

Promoter holding53.65%

Unchanged over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026Change
Promoter53.6553.6553.6553.6553.6553.6553.6553.650.0
FII0.01000.470000-0.01
DII000000000
Public46.3446.3546.3545.8846.3546.3546.3546.35+0.01

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for LASA are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about LASA

What is the market cap of LASA?

LASA has a market capitalisation of about ₹22 crore.

How are LASA's latest results?

Promoter holding was 53.65% in Sep 2026, up 0.00 points over 8 quarters.

Who owns LASA?

As of Sep 2026, shareholding was: Promoter 53.65%, Public 46.35%.

How many mutual funds hold LASA?

0 mutual fund schemes held LASA in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 16 Sep 2022 · Dividend - Rs. 0.25
  • 15 Sep 2021 · Dividend - Rs. 0.25

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.